David Vaughan Investments »

Abcellera Biologics shares owned by David Vaughan Investments

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by David Vaughan Investments from 13F filings

Historical chart of David Vaughan Investments investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by David Vaughan Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by David Vaughan Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $35k 10k 3.50

More positions owned by David Vaughan Investments

Broadcom avgo (AVGO)
Lam Research Corp lrcx (LRCX)
Microsoft Corp msft (MSFT)
Jp Morgan Chase & Co jpm (JPM)
Deere & Co de (DE)
Entergy Corp etr (ETR)
Johnson & Johnson jnj (JNJ)
Abbvie abbv (ABBV)
Alphabet Inc Cl A googl (GOOGL)
Cisco Systems csco (CSCO)
Conocophillips cop (COP)
Williams Cos wmb (WMB)
American Express axp (AXP)
Goldman Sachs Group gs (GS)
Exxon Mobil Corporation xom (XOM)

View all positions for David Vaughan Investments

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Two Sigma Investments
TD Waterhouse Canada
Ubs Global Asset Management Americas
Leucadia National Corporation
UBS Group
Arrowpoint Asset Management
BlackRock
Driehaus Capital Management
Goldman Sachs Group
Bank of America Corporation
Alyeska Investment Group
Renaissance Technologies
Tudor Investment Corporation

View all funds holding Abcellera Biologics